Steris (STE): Royal London Asset Management Ltd reduced its stake -134K shares
Royal London Asset Management Ltd reduced its stake in Steris, per its Q2 2026 13F.
- 423K
- Shares reported · -134K vs prior quarter
- 0.16%
- Disclosed portfolio weight
- $89.1M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 13, 2026
What stands out in this filing
- 556,926 shares in Q1 2026, 423,135 now (−24.0% in share count).
- Reported at $89.1M, 0.16% of the portfolio value in this 13F filing.
- 35 other tracked managers reported the same kind of change for Q2 2026.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 31, 2026, Pierre Boulud was appointed to serve on the Audit Committee of the Board and the Compliance and Technology Committee of the Board.”
- Jun 15, 2026InsiderOfficer sold ~$297K of STE shares in the open market
- Jun 24, 2026FDAFDA device clearance: AMSCO 700 Steam Sterilizer
- Jul 13, 2026CongressDisclosed sale of STE — reported range $1,001 - $15,000
- Jul 24, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 27, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 29, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 31, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Aug 5, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina.”
- Aug 12, 2026InsiderDirector sold ~$957K of STE shares in the open market
What came next
- Aug 25, 2026CongressDisclosed sale of STE — reported range $100,001 - $250,000
- Aug 31, 2026FDARecall: VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3060
- Aug 31, 2026FDARecall: VERIFY Biological/Integrator Challenge Pack Model/Catalog Number: LCB007
- Aug 31, 2026FDARecall: VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3061
- Aug 31, 2026FDARecall: VERIFY Biological/Integrator Challenge Pack Model/Catalog Number: LCB006
- Aug 31, 2026FDARecall: VERIFY Biological Steam Test Pack Model/Catalog Number: S3065
- Aug 31, 2026FDARecall: VERIFY Biological Steam Test Pack Model/Catalog Number: S3069
- Sep 15, 2026CongressDisclosed sale of STE — reported range $15,001 - $50,000
- Sep 21, 2026FDARecall: RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020116
- Sep 21, 2026FDARecall: RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020115
- Sep 21, 2026FDARecall: RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020117
- Sep 23, 2026FDARecall: HexaVue Focus Integration System, a single, all-in-one system that handles operating room video routing, surgical video integration, and environmental control,…
- Oct 2, 2026FDAFDA device clearance: MEDIVATORS ADVANTAGE NXT Automated Endoscope Reprocessor
- Oct 11, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Oct 28, 2026FDAFDA device clearance: VERIFY RESI-TEST SWAB Protein Detection Indicator
- Oct 29, 2026FDAFDA device clearance: V-Pro maX 2 Low Temperature Sterilization System
- Nov 4, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results
- Nov 4, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Nov 10, 2026Insider · 1 personInsiders: 2 sales (~$1.2M)
- Nov 11, 2026InsiderCFO sold ~$1.5M of STE shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Steris
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.
How this filing works
Explore the data
Common questions
What does this filing report about Steris (STE) stock?
Royal London Asset Management Ltd reduced its stake in Steris, per its Q2 2026 13F. Now 423K shares, $89.1M reported value, 0.16% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2026. Filed: Aug 13, 2026.
What stands out in this filing?
556,926 shares in Q1 2026, 423,135 now (−24.0% in share count). Reported at $89.1M, 0.16% of the portfolio value in this 13F filing. 35 other tracked managers reported the same kind of change for Q2 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Steris recently?
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days. They are listed on the STE page.
Does this mean STE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Steris
- SEC Form 4Nov 17, 2026
- SEC Form 144Nov 13, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
Everything OQRO holds on this company is on its STE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
